Table 4.
# | Compound | Classa | Retention indexb | Source | |
---|---|---|---|---|---|
1 | Ac | Nepetalactone (cis-trans-nepetalactone) | Type II lactone | 1383 | Synthesized |
2 | A | Epinepetalactone (trans-cis-nepetalactone) | Type II lactone | 1416 | Synthesized |
3 | B | Dihydronepetalactone | Type II lactone | 1490 | Synthesized |
4 | B | Isodihydronepetalactone | Type II lactone | 1446 | Synthesized |
B | trans-dihydronepetalactoned | Type II lactone | 1505 | Synthesized | |
B | trans-isodihydronepetalactoned | Type II lactone | 1470 | Synthesized | |
5 | C | Neonepetalactone | Type II lactone | 1517 | Synthesized |
6 | C | Isoneonepetalactone | Type II lactone | 1511 | Synthesized |
7 | D | Iridomyrmecin | Type I lactone | 1466 | Synthesized |
8 | D | Isoiridomyrmecin | Type I lactone | 1478 | Synthesized |
9 | Actinidine | Pyridine | 1348 | Synthesized | |
10 | Dihydroactinidiolide | Furanone | 1562 | AK Scientific | |
11 | Indole | AK Scientific | |||
12 | Menthol | GreenHealth | |||
13 | Methyl salicylatee | TCI Chemicals |
a The difference between type I and II lactones is the position of the carbonyl group [30]
b Linear retention index relative to n-alkanes on a DB-5ms column
c The same letters in the second column of this table indicates these compounds are diastereoisomers: stereoisomers with one or more differing stereocenters resulting in different molecules that are not mirror images and not superimposable
d These compounds were only prepared in small amounts and used as standards in the GC-MS analysis, but were not used in bioassays with cats
e Liquid at room temperature